The conceptual basis of the invention is based on the identification of a Rapamycin specific target and complex formation, which enabled the design and production of recombination fusion proteins as the basis for a simple ELISA based chromogenic reaction.
The conceptual basis of the invention is based on the identification of a Rapamycin specific target and complex formation, which enabled the design and production of recombination fusion proteins as the basis for a simple ELISA based chromogenic reaction.
一种雷帕霉素特异性靶点的鉴定和复合物的形成，是这项发明的概念基础，它们使重组融合蛋白的设计和生产成为一项基于显色反应的简单酶联免疫吸附分析的基础。